Intervacc
  • About us
    • Management
    • Board of directors
    • Our History
    • Partners
  • Research & Development
    • Pipeline
    • Technology platform
    • Patents
    • Publications
  • Products & Services
    • Vaccines and pharmaceuticals
    • Analyses
  • Investors
    • Market
    • Reports
    • Calendar
    • The share
    • Shareholders
    • Certified Adviser
    • Corporate Governance
  • Press
    • Press materials
    • News
    • Legal Press releases
    • Other Press releases
  • Contact
  • Search
  • Swedish

Reports

Intermin reports 2022Intermin reports 2021Year-end report jan-dec, 2020Interim report jan-mar, 2019Interim report jan-mar, 2018
2022202120202019other
Interim reportsAnnual reportAnnual reportAnnual reportAnnual report 2018
- July - September- October - December- October - December- October - December
Annual report 2017
- April - June- July - September- July - September
- July - September
Annual report 2016
- January - March- April - June- April - June- April - June
Annual report 2015
- January - March- January - March- January - MarchAnnual report 2014
Annual report 2013

 

Please notice that all financial reports published before September 2020 are in Swedish only

Postal address: Box 112, SE-129 22 Hägersten
Visiting address: Västertorpsvägen 135,
SE-129 44 Hägersten
Phone: 08-120 10 600
Fax: 08-120 10 640
Email: info@intervacc.se